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Abstract
Introduction: Percutaneous transhepatic portal embolization is often performed to expand the indications for
hepatic resection. Various etiologies of hepatic artery pseudoaneurysm have been reported, but regardless of the
etiology, hepatic artery pseudoaneurysm is usually managed with an endovascular approach or open surgery,
depending on the location and clinical symptomatology. However, it is difficult to manage hepatic artery
pseudoaneurysm after percutaneous transhepatic portal embolization, since embolization of the hepatic artery may
cause hepatic infarction
Case presentation: A 58-year-old Japanese man with hilar bile duct cancer underwent percutaneous transhepatic
portal embolization to expand the indication for hepatic resection. Two days after percutaneous transhepatic portal
embolization, our patient suddenly complained of abdominal pain. Contrast-enhanced computed tomography
confirmed a pseudoaneurysm arising from a segmental branch of his right hepatic artery. Since embolization of
the hepatic arterial branches may cause hepatic infarction, ultrasound-guided thrombin injection therapy was
successfully performed for the pseudoaneurysm.
Conclusion: We performed a thrombin injection instead of arterial embolization to avoid hepatic infarction. The
rationale of this choice may be insufficient. However, ultrasound-guided percutaneous thrombin injection therapy
may be considered as an alternative to percutaneous transarterial embolization or surgical intervention for an
iatrogenic hepatic artery pseudoaneurysm.
Introduction
Percutaneous transhepatic portal embolization (PTPE) is
often performed to expand the indications for hepatic
resection. Various etiologies of hepatic artery pseudoa-
neurysm (HAP) have been reported, but regardless of the
etiology, HAP is usually managed with an endovascular
approach or open surgery, depending on the location and
clinical symptomatology. However, it is difficult to man-
age HAP after PTPE, since embolization of the hepatic
artery may cause hepatic infarction. We herein describe a
case of PTPE complicated by a HAP, in which the HAP
was successfully managed with an ultrasound (US)-
guided thrombin injection technique.
Case presentation
A 58-year-old Japanese man with hilar bile ductal carci-
noma underwent preoperative PTPE to expand the indi-
cation for right hepatic resection. We punctured the
anterior branch of his right portal vein with a 21-gauge
needle under US-guidance. A 5-Fr sheath was advanced
into the portal branch and a 5-Fr balloon catheter was
inserted into the anterior and posterior branches of his
right portal vein. After inflating the balloon, absolute
alcohol was injected. A portography confirmed the com-
plete occlusion of these portal branches. Finally, two
5 mm × 5 cm 0.035-inch coils were deployed to perform
tract embolization after PTPE. During these procedures
our patient was asymptomatic.
Two days later, our patient suddenly complained of an
acute abdominal pain, but his vital signs remained stable.
A contrast-enhanced computed tomography (CT) con-
firmed the presence of a pseudoaneurysm arising from a
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segmental branch of his right hepatic artery: the pseudoa-
neurysm measured 20 × 15 mm in size with a narrow
neck surrounded by hematoma (Figure 1a). Percutaneous
transarterial embolization (TAE) of the pseudoaneurysm
was considered to be inappropriate, since TAE may cause
hepatic infarction because of an already occluded portal
vein. Under US and digital subtraction angiography
(DSA) guidance (Figure 1b), the pseudoaneurysm was
punctured with a 21-gauge needle and 1500 U of human-
derived thrombin was injected into the pseudoaneurysm
(Figure 2). Total occlusion of the pseudoaneurysm was
confirmed by DSA and follow-up CT (Figure 3), and an
occlusion of the segmental branch of his right hepatic
artery was avoided. Our patient was followed-up for four
weeks after the procedure using US, and there was no
evidence of recurrent pseudoaneurysm or hepatic infarc-
tion. The left lobe of his liver became hypertrophic.
He underwent a right hepatectomy 30 days after the pro-
cedure, and his postoperative course was uneventful.
Discussion
Post-traumatic HAP is uncommon, and accounts for
approximately 1% of hepatic trauma cases [1,2]. Other
causes include chronic pancreatitis, orthotopic liver
transplantation, arteriosclerosis, cystic medial necrosis,
polyarteritis nodosa, necrotizing vasculitis, acute pancrea-
titis and hepatocellular carcinoma [2]. Most HAPs occur
extrahepatically, predominantly in the right hepatic artery
[2]. Intrahepatic HAPs account for only about 20% of all
HAPs and are often a complication of percutaneous pro-
cedures such as transhepatic cholangiography, transhepa-
tic catheter placement or liver biopsy [3]. The incidence
of intrahepatic HAP occurring after trauma is relatively
uncommon.
There is only one report of PTPE complicated by HAP,
and it occurred in one of 47 procedures (2.1%) [4]. How-
ever, to the best of our knowledge, there have been no
reports in the English literature describing treatment of
HAP complicated by PTPE. In the present case, we sus-
pected that the HAP may have been caused by unex-
pected damage of the hepatic arterial branch when we
accessed his right portal vein. Rupture of a HAP is asso-
ciated with a high mortality rate, thus it mandates an
early detection and prompt intervention [1,2]. Although
clinical diagnosis can be made by noninvasive methods
such as CT and Doppler US, selective catheter arteriogra-
phy remains the most sensitive modality for detecting a
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Figure 1 Pseudoaneurysm (arrow) arising from the right
hepatic artery branch. (a) Contrast enhanced CT of the upper
abdomen. (b) DSA of the proper hepatic artery.
Figure 2 US-guided thrombin injection therapy for an
iatrogenic hepatic artery pseudoaneurysm with 21G needle
(arrow).
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HAP. In a study by Tobben et al. [5], catheter arteriogra-
phy detected all HAPs in ten patients, compared with
only 67% by CT and 33% by Doppler US. Selective arter-
iography may also show active bleeding and anatomic
variations such as an anomalous or replaced hepatic
artery [6], and can be used in simultaneous diagnosis and
treatment. The recent extended utilization of high-reso-
lution vascular imaging modalities may have a greater
contribution.
Selective arterial embolization is currently considered to
be the most appropriate technique in the treatment of
visceral pseudoaneurysms, with a success rate of more
than 80% and a low complication rate [7]. Various agents
for embolization have been used successfully, such as etha-
nol, gel foam particles, microcoils, n-butyl-2-cyanoacrylate
glue, polyvinyl alcohol particles and thrombin [8,9] as well
as metallic stents and detachable silicone balloons [10].
Percutaneous thrombin injections for the treatment of
visceral [11], renal [12] and extremity pseudoaneurysms
have been employed since 1986 and were first described by
Cope and Zeit [13], and can be performed under Doppler
US-guidance. This method has yielded excellent results for
femoral pseudoaneurysms, and can be carried out without
the need of anesthesia equipment or an operating theater.
We selected the percutaneous thrombin injection techni-
que under US and DSA-guidance to avoid hepatic artery
occlusion which may result in hepatic infarction.
As well as the possibility of a recurrent pseudoaneur-
ysm after a percutaneous thrombin injection, complica-
tions such as thromboembolism and allergic reactions
have limited its use [13]. The use of bovine-derived
thrombin may pose a potential risk of an allergic
response and hemorrhage in patients with a known
allergy to bovine-derived products or previous exposure
to topical thrombin [13]. Another consequence of
bovine thrombin exposure is the potential development
of antibodies to human clotting proteins and thrombin,
in particular factor V, resulting in coagulopathy and
excessive bleeding [14]. Such complications are not seen
with newer human-derived thrombin.
Conclusion
A HAP is one of the possible complications following
PTPE. Generally, such a complication will be managed
by an endovascular approach. Although minor hepatic
infarction can occur after hepatic arterial embolization,
liver damage induced by hepatic arterial embolization in
such cases may usually be within an acceptable range.
We performed thrombin injection instead of arterial
embolization to avoid hepatic infarction. The rationale
for this choice may be insufficient. However, US-guided
percutaneous thrombin injection therapy may be consid-
ered as an alternative to TAE or surgical intervention
for an iatrogenic HAP.
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Figure 3 Confirmation of the total occlusion of the
pseudoaneurysm on (a) DSA and (b) follow-up CT.
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